Healthcare MoneyTree™ report: Q2, 2020

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

Top five US Healthcare industries over the last five quarters:

Top five US Healthcare industries over the last five quarters

Highlights for this quarter's report include, but are not limited to:

  • In the US: Funding for VC-backed Healthcare companies in US raised $6.4B in 197 deals.
  • Compared to Q1’20, the number of deals closed in Q2’20 decreased by 2% from 200 to 197.
  • Of the $6.4B raised in Q2’20, $2.7B was invested in the Biotechnology subsector while $1.4B was invested in the Drug Development industry.
  • A total of $2.6 was raised this quarter through 14 mega-rounds*, making up 40% of total deal dollars raised in Q2’20.
  • In Q2’20, New England raised $2.2B through 45 deals and is the leading region this quarter in terms of dollars raised. There were 7 mega-rounds in New England.
  • There were 14 Healthcare IPOs in Q2’20 raising approximately $2.4B.
  • Globally: dollars invested increased to $10.7B in Q2’20, while the number of deals increased from 427 in Q1’20 to 507 in Q2’20.

Contact us

Ousmane Caba

Partner, US Pharmaceuticals and Life Sciences, PwC US

Laura Robinette

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Tim Weld

US Health Industries Assurance Leader, PwC US

Follow us